A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it counts—in the saliva of older people most vulnerable to the explosive ...

researchers found that the neutralizing antibodies persisted in the mouse models eight months after vaccination. When a different influenza strain was introduced, the vaccine protected against ...

This study explores the potential of oncomicrobial vaccines in mitigating tumor progression by targeting specific cancer-promoting microbes in mice. The researchers developed and tested vaccines ...

However, at least three different inactivated vaccines, based on purified suckling-mouse brains, golden hamster kidney cells or Mongolian gerbil kidney cells, were developed in Korea and/or China ...

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

A vaccine's ability to generate long-lasting ... The findings were confirmed in mouse immunization studies involving model antigens as well as exposure to the receptor-binding domain of the ...